Global stock

NYSEUSD

UiPath Inc.

PATH

AI analysis and articles are in Czech.

§ Financial healthLong-term stability

62/ 100

Overall score·PATH

Current price

14.13USD

23/10/2026

P/E, P/B

Valuation

Neutral

Rates whether the stock is cheap or expensive relative to its history and sector. A score above 60 suggests the stock trades below its estimated intrinsic value.

Tracks:P/E · P/B · FCF yield · sector

Aktivum se obchoduje s Forward P/E kolem 16,5 a PEG 0,65, což naznačuje podhodnocení vzhledem k růstu a ziskovosti. P/E je nižší než sektorový průměr, P/S je relativně vysoké, EV/EBITDA je vysoké. Historický růst tržeb výrazně posiluje EPS, ale zadluženost a marže ukazují na tlak na ziskovost při expanzi. Celkove trend ukazuje na pozvolný růst, nicméně volatilita je vyšší a fixní rizika souvisejí s IT cykly a konkurencí.

§ Outlook vs S&P 500Next 12 months

Probably yes

Estimated chance of beating the index: about 58%

8 of 8 inputs

NoProbably notSameProbably yesYes

A model estimate from current values. The result may change with new data; it is not a price target or an investment recommendation.

§ Metrics summary

A quick look at UiPath Inc. (PATH) combining financial health, the short-term signal, valuation, DCF, management quality and operating metrics. It is analytical context, not a recommendation to buy or sell.

62/100

The overall score is based mainly on long-term fundamentals, complemented by the current signal and the available qualitative rating of the company.

56/100

Slightly positive signal based on current news, price action and the economy.

53/100

A lower score means the stock is expensive relative to the company's earnings and assets.

1% below fair value

An estimate of what the stock should be worth based on the company's future cash.

+13%

How fast the company's revenue grows year on year.

62/100

How much the company earns from each unit of revenue and from invested capital.

58/100

Debt level, share-price volatility and how resilient the company is in bad times.

78/100

AI estimate of management quality, execution and capital allocation.

68/100

AI estimate of the company's durable competitive advantage.

§ Context and events

Management

Spoluzakladatel Daniel Solomon Dines je CEO a výkonným předsedou představenstva. Ashim Gupta působí jako COO; Hitesh Ramani zastává funkci CFO a hlavního účetního. Strategie společnosti staví na automatizaci podnikových procesů a rozšiřování platformy o AI.

Articles about UiPath Inc., in Czech (0)

No articles yet. New analyses are published daily.

§ Upcoming results

2 December 2026

in 36 days

Earnings

Earnings = quarterly financial results (revenue and profit). Companies publish them every three months and the share price often reacts strongly.

§ Frequently asked questions

What is UiPath Inc. (PATH)?

UiPath Inc. (PATH) is a global stock traded on NYSE. We track it daily — scoring news sentiment, the short-term outlook and long-term stability on a 0–100 scale.

What is the UiPath Inc. price today?

As of 23 October 2026, UiPath Inc. trades at about 14.13 USD per unit. We update the price daily from public market data. Intraday moves can differ significantly — always check the final price with your broker.

How to buy UiPath Inc.?

Through regulated online brokers such as Degiro, XTB, Trading 212 or Interactive Brokers. Shares trade in USD or EUR — most brokers convert your currency automatically. FinSignal does not operate any of these platforms and charges no commission — the overview is only a signpost.

Does UiPath Inc. pay a dividend?

UiPath Inc. either pays no dividend at the moment or we have no reliable data on it. Many growth companies prefer reinvesting profit to paying dividends — check the current policy in the company's investor relations materials.

Is UiPath Inc. a good investment in 2026?

Our AI signal currently rates UiPath Inc. as slightly positive (score 56/100). Financial health comes out at 62/100, so beyond short-term news it is worth watching the valuation, growth, profitability and stability of the company. The DCF model currently puts the price about 1 % below its model fair value. FinSignal is not an investment adviser licensed under Czech Act No. 256/2004 Coll. — signals are analytical input, not a recommendation to buy or sell. You make every decision at your own risk.

§ More global stocks

Microsoft Corporation

Advanced Micro Devices

§ How to buy UiPath Inc.

You can buy shares through regulated online brokers available in the EU. They differ mainly in fees, app quality and which markets they cover.

Degiro
Dutch broker with low fees for passive investors. No account fee, trading in EUR and USD.
XTB
Polish broker with zero commission on stocks and ETFs up to EUR 100,000 a month. Own xStation platform.
Trading 212
Zero-commission broker with fractional shares from EUR 1 and automated investing (Pies). Suits beginners and regular investing.
Interactive Brokers
US broker for advanced investors. The widest choice of markets, low costs at larger volumes, a professional platform with a steeper learning curve.

FinSignal operates none of these platforms. We charge no commission on purchases.

Important: Signals are an analytical tool, not investment advice within the meaning of Czech Act No. 256/2004 Coll. Past performance does not guarantee future results. You make all decisions at your own risk.

§ Current signalShort-term mood

/ 100

● Slightly positive

News summary

Fresh news

Signal 27/10, 04:02

UiPath podle zprávy překonal výkonnost trhu; oznámený prodej akcií insiderem za 413 963 USD může sentiment brzdit, pokud se přidají další prodeje.

Růst ceny o 9,96 % za týden a 12,14 % za měsíc spolu s rostoucím trendem a RSI 56 podporují krátkodobý výhled. Předchozí obavy o růst a návratnost zákazníků omezují střednědobý optimismus.

Risks: Pokud se růst ceny obrátí nebo se potvrdí další zpomalování ARR a slabá návratnost zákazníků, pozitivní technický obraz může rychle slábnout.

More about the signal

Risks: Pokud se růst ceny obrátí nebo se potvrdí další zpomalování ARR a slabá návratnost zákazníků, pozitivní technický obraz může rychle slábnout.

Signal history· 2

24/1013:0148 · Neutral
BofA 23. října snížila cílovou cenu UiPath z 15 na 12 USD a ponechala negativní hodnocení; případné zlepšení růstu a zákaznické návratnosti by tlak zmírnilo.
21/1021:0348 · Neutral
UiPath po výsledcích za Q2 vykázal ARR 1,94 mld. USD; článek upozorňuje na zpomalený růst a slabší návratnost akvizice zákazníků. Stabilní ARR by obavy zmírnilo.

The full 90-day signal history is part of Premium.

Ask the AI

§ Model fair value (DCF)

Fairly valued1% below fair value

14.26

range 11.5 – 18.2

Current price

14.13 USD

23 Oct 26

PriceFair value range (DCF)UndervaluedOvervalued

What the calculation is based on

Model

14.26 USD

range 11.5 USD – 18.2 USD

: 12.0%
: 9.5%
: 0.66 USD

Růst FCF 12 % p.a. odráží růst tržeb 13 % a růstový profil softwarové společnosti, zároveň počítá s možným kolísáním cash flow. Diskontní sazba 9,5 % zohledňuje betu blízko 1 a rizika technologického sektoru; terminální růst 2,5 % odpovídá dlouhodobému tempu ekonomiky.

DCF terms explained+

DCF (discounted cash flow) estimates how much cash the company will generate in the future and converts it into today's value per share.

Free cash flow (FCF) is the money left after running the business and investing. “12 m” means the last 12 months.

The discount rate expresses risk: the riskier the company, the higher the rate and the lower the fair value.

Fair value is a model estimate — not the market price and not an investment recommendation.

With Premium you can adjust growth, the discount rate and free cash flow, and the fair value recalculates live.

Adjust assumptions14 days free →

A model estimate, not an investment recommendation. Past performance does not guarantee future results.

§ Valuation check

Is the price reasonable?

Six quick tests: price against fair value, the last year, similar companies and analyst estimates. They are calculated from the numbers, not from AI estimates. This is not a recommendation.

Data 18 of 18

Valuation score

4/ 6

6/6 tests available

1. Below DCF fair value

0.9% below the DCF midpoint.

2. Well below DCF value

Discount = below the range or at least 15% below the midpoint.

3. Price vs. the last year

51% above the 1-year low (9.38 USD to 18.67 USD), based on stored daily prices.

4. P/E vs. similar companies

P/E 22.7 vs. median 35.2 (73 companies).

5. P/E relative to growth

PEG 0.7; a lower value means cheaper growth.

6. Analyst price target

16.6% vs. the current price, 16 analysts.

Price vs DCF

Current price

14.13 USD

Low 11.45 USDHigh 18.16 USD

Current priceDCF midpoint: 14.26 USD

Price vs analyst target

Current price

14.13 USD

Low 10.98 USDHigh 22.00 USD

Current priceAverage: 16.47 USD

DCF gap

within range

The price is within the model range of 11.45 USD to 18.16 USD.

Analyst target

+16.6%

Average target 16.47 USD vs. price 14.13 USD.

Analyst consensus

Target range

10.98 USD - 22.00 USD

Coverage

16 analysts

Analyst consensus

2.8 / 5

Changes 180 d

+1 / -1

EPS next year

16.9%

Revenue next year

8.4%

Valuation multiples

22.7

16.5

4.1

4.6

36.1

0.7

52-week range51% above the low

9.38 USD18.67 USD

2,281.0%

13.0%

21.0%

20.0%

Price vs 50D1.7%

Price vs 200D9.6%

Metrics explained+

Price and fair value

DCF range: A model estimate of fair value from future free cash flow. A price above the range means the market pays a premium over the model; a price below it may signal a more conservative market valuation or an overly optimistic model.
Analyst target: The average and range of the analyst price targets we track. It is the market consensus, not a FinSignal recommendation, and it can lag fast price moves.
52-week range: Shows where the current price sits between the low and high of the last year. A value near the high often signals strong momentum, but on its own says nothing about whether the stock is expensive.
Price vs 50D / 200D: Compares the price with its short- and long-term moving averages. A positive value means the price is above the trend; a negative one below it.

Multiples

P/E: Price relative to current earnings. A lower P/E can mean cheaper, but it can also point to a weak outlook or risk.
Forward P/E: Price relative to next year's expected earnings. For growing companies it is often more useful than the historical P/E because it reflects estimates of future earnings.
P/B: Price relative to the book value of equity. It makes more sense for banks, insurers and capital-intensive companies than for software or brands.
P/S: Price relative to revenue. It helps with companies that have low or negative earnings; a high P/S means the market expects strong growth or future margins.
EV/EBITDA: The value of the whole company, including debt, relative to operating profit before depreciation. Useful for comparing companies with different leverage.
PEG: P/E adjusted for earnings growth. A value around 1 may suggest the valuation matches growth, but the metric is sensitive to estimates.

Growth and quality

EPS growth: Year-on-year change in earnings per share. Strong growth supports a higher valuation, but for cyclical companies it can be temporary.
Revenue growth: The growth rate of sales. It helps tell whether profits grow on real demand or mainly on cost savings.
Net margin: How much of each unit of revenue is left as net profit. A higher margin often points to stronger pricing power or more efficient operations.
ROE: Return on equity. A high ROE can signal a quality business, but check that it is not artificially boosted by heavy debt.

Most data available. Missing values mean the market data source did not provide them for this ticker. The data is indicative and may be delayed. Price as of 23/10/2026.

Management and competitive advantage

Both are estimated by the AI from the company profile, news and results. They do not count towards the 6-pillar financial health score. The AI comments are in Czech.

strong

Vedeni Ma na cerstvu tracku rastu a alokace kapitálu, ale panel rizik je konzistentni s kulturem rizik a regulatorni exekuci.

good

Moderatní moat díky významné platformě RPA a integracím, ale zisková soutěž s hlavními hráči snižuje dlouhodobou bariéru vstupu.

Information

Type: Global stock
Symbol: PATH
Exchange: NYSE
Currency: USD
Sector: Informační technologie
: 22.7x
: 7.9B USD
: 3.6 %
: 1.02

§ Risk profile

Rizikem je konkurence v automatizaci a AI, pomalejší rozšiřování zakázek u stávajících zákazníků a vysoká citlivost ocenění na výhled růstu. Český investor navíc podstupuje měnové riziko USD/CZK.

Ask the AI about UiPath Inc.All signals